|Bid||0.00 x 1300|
|Ask||0.00 x 1000|
|Day's Range||5.22 - 6.06|
|52 Week Range||4.11 - 22.61|
|Beta (5Y Monthly)||1.35|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 15, 2022 - Aug 19, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||18.34|
Subscribe to Yahoo Finance Plus to view Fair Value for DRIO
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced a new contract to deliver its digital behavioral health solution for a leading provider of integrated technology solutions for financial professionals. The new account is expected to launch in the third quarter of 2022.
Solera Health, the premier platform for connecting people seamlessly and easily to proven, personalized health solutions, announces its partnership with DarioHealth, a leading digital therapeutics company revolutionizing how people with chronic conditions manage their health through a user-centric platform. Together, Solera and DarioHealth are offering a turnkey, world class solution for treating hypertension, requiring just one contract and one technical integration to make this compelling new
DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, announced today it closed a senior secured term loan facility of up to $50 million with OrbiMed, a leading investor in the healthcare industry, providing non-dilutive capital to fund the continued development of its platform and the acceleration of its adoption in the multi-billion dollar global chronic disease management market.